Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Aug 14, 2024 8:30am
66 Views
Post# 36178087

RE:RE:RE:RE:Q2 Results

RE:RE:RE:RE:Q2 Results
Macpoor wrote: I am waiting what the management team will say in an hour.  I hope that they give us a clear message for upcoming months ahead. You never know . The world of stock market is full of surprises and ambiguities!

At the end , I just wish to have power to move those stock to at least over 30 cents:))

Good luck!


Management call will be a waste of time.  They will do nothing more than say they are pleased with the progress and trend and that things are headed in the right direction.  They will not go off script from what the NR states, and, I expect, will just simply point to 'ongoing initiatives' for future positivity without speaking to what those things are.

No matter how you look at this NR, it's an abject failure.  Just (almost) breaking even, when the global market is expanding and you can't grow revenues does not a successful business make.  So ya, they can celebrate almost EBITDA positive, but no one will care if they best they can do is $10M, with Drob sales no less.
<< Previous
Bullboard Posts
Next >>